SMTL ID : 5kz8.2 (1 other biounit)

Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.21 Å

Oligo State

monomer

Ligands

1 x 6Z5: 5,5-dimethyl-7-[(1~{S})-4-oxidanyl-1~{H}-inden-1-yl]-2-phenylazanyl-pyrrolo[2,3-d]pyrimidin-6-one(Non-covalent)

6Z5.1: 14 residues within 4Å: Chain A: I.41, V.49, A.62, K.64, V.95, M.111, E.112, Y.113, A.114, G.117, E.118, E.161, L.164, D.175 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.49, A:A.62, A:V.95, A:M.111, A:L.164, A:L.164 Hydrogen bonds: A:A.114, A:A.114

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Katz, J.D. et al., Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors. Bioorg. Med. Chem. Lett. (2017)

Release Date

2017-05-31

Peptides

Serine/threonine-protein kinase MARK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Serine/threonine-protein kinase MARK2

Related Entries With Identical Sequence